NEUROCRINE GROUP LIMITED

Company number 09846650

Date	Type	Description	View / Download
11 Nov 2022	RR02	Re-registration from a public company to a private limited company	(2 pages)
09 Nov 2022	TM01	Termination of appointment of Richard Ross as a director on 1 November 2022	(1 page)
03 Nov 2022	AP01	Appointment of Matthew Charles Abernethy as a director on 1 November 2022 ANNOTATION Clarification a second filed AP01 was registered on 13/01/2023.	(3 pages)
03 Nov 2022	AP01	Appointment of Malcolm Charles Lloyd-Smith as a director on 1 November 2022 ANNOTATION Clarification a second filed AP01 was registered on 14/01/23	(3 pages)
03 Nov 2022	AP01	Appointment of Darin Michael Lippoldt as a director on 1 November 2022 ANNOTATION Clarification a second filed AP01 was registered on 13/01/2023.	(3 pages)
03 Nov 2022	AP01	Appointment of Kevin Charles Gorman as a director on 1 November 2022 ANNOTATION Clarification a second filed AP01 was registered on 13/01/2023.	(3 pages)
03 Nov 2022	TM01	Termination of appointment of Alan Michael Raymond as a director on 1 November 2022	(1 page)
03 Nov 2022	TM01	Termination of appointment of Karl Anders Olof Harfstrand as a director on 1 November 2022	(1 page)
03 Nov 2022	TM01	Termination of appointment of John Geoffrey Goddard as a director on 1 November 2022	(1 page)
03 Nov 2022	TM01	Termination of appointment of Jean-Michel Yves Sylvain Cossery as a director on 1 November 2022	(1 page)
03 Nov 2022	TM01	Termination of appointment of Deborah Ann Jorn as a director on 1 November 2022	(1 page)
03 Nov 2022	TM01	Termination of appointment of Dr Samuel Cameron Williams as a director on 1 November 2022	(1 page)
02 Nov 2022	OC	Scheme of arrangement	(9 pages)
30 Oct 2022	SH01	Statement of capital following an allotment of shares on 28 October 2022 GBP 8,743,000.4	(3 pages)
27 Oct 2022	RESOLUTIONS	Resolutions RES01 ‐ Resolution of alteration of Articles of Association RES13 ‐ Scheme agreement 21/10/2022	(2 pages)
27 Oct 2022	CS01	Confirmation statement made on 27 October 2022 with no updates	(3 pages)
27 Oct 2022	MA	Memorandum and Articles of Association	(67 pages)
09 Aug 2022	SH01	Statement of capital following an allotment of shares on 15 July 2022 GBP 8,502,041.25	(3 pages)
05 Apr 2022	TM01	Termination of appointment of Martin James Whitaker as a director on 4 April 2022	(1 page)
28 Mar 2022	SH01	Statement of capital following an allotment of shares on 8 February 2022 GBP 8,466,493.45	(3 pages)
16 Dec 2021	AP01	Appointment of Dr Jean-Michel Yves Sylvain Cossery as a director on 12 December 2021	(2 pages)
16 Dec 2021	AA	Group of companies' accounts made up to 30 June 2021	(94 pages)
16 Dec 2021	AP01	Appointment of Ms Deborah Ann Jorn as a director on 12 December 2021	(2 pages)
16 Dec 2021	AP01	Appointment of Dr Karl Anders Olof Harfstrand as a director on 12 December 2021	(2 pages)
06 Dec 2021	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES09 ‐ Resolution of authority to purchase a number of shares RES13 ‐ Co business 19/11/2021 RES10 ‐ Resolution of allotment of securities	(3 pages)

Previous

• 1
• 2
• 3
• 4
• 5
• 6

Next